Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

BioMarin Pharmaceutical

ClinicalTrials.gov Identifier:

NCT00925054

First received: June 17, 2009

Last updated: March 31, 2013

Last verified: March 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2013
Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)